Assen S. Kirov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Assen S. Kirov has a total of 214 co-authors. Here are the top co-authors by number of shared publications:
- Charles Ross Schmidtlein
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
6 shared publications Stephen B. Solomon
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York
6 shared publicationsHeiko Schöder
Unit of Nuclear Medicine, Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
5 shared publicationsJohn L. Humm
Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA
5 shared publicationsConstantinos T. Sofocleous
Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY USA
4 shared publications- Constantinos T. Sofocleous
Interventional Radiology Service, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
4 shared publications
Latest Publications
- 6 May 2026
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 12 (3) , 035022
A strategy of CT exam protocol to standardize groups of scanners using automated noise assessment and noise prediction for CT radiotherapy simulation
Objective. Standardizing clinical CT images enables consistent analysis of image data for target delineation, radiomics, and machine learning in personalized medicine. The process of managing the scanned protocols in various CT scanners for radiotherapy simulation is underexplored in the literature. This study uses noise evaluation and prediction models to harmonize CT protocols across scanner models and manufacturers, ensuring reliable data for radiotherapy planning. Approach. A global noise index (GNI) was calculated from 1581 clinical CT exams obtained on five scanners (three from vendor P and two from vendor S: S p and S c ). Exams were categorized by anatomical site. GNI was assessed (I) within the same model, (II) between models from the same manufacturer, and (III) across manufacturers. One-way ANOVA (I, III) and student t -tests (II) evaluated significance ( p < 0.05). Predictive models were created and validated with 90 further exams, establishing a reference GNI (GNI ref ) for future optimization. Results. GNI showed minor variations among P-type and between S p and S c scanners, but S scanners differed from P . Predictive model error ranged from 0.8 to 1.5 hounsfield units (HU). GNI differences between S and P scanners were S scanners had 1.5–2 HU higher GNI for the abdomen, pelvis, breast, and lungs. Conclusion. Scanners of the same model show slight variation; minor noise differences exist between manufacturers. Predictive modeling can estimate CT noise and support protocol optimization. The reference GNI of an anatomical site can be derived from sufficient CT exams, with or without the predictive mode; a 1–2 HU difference in GNI ref is achievable if the protocol is properly translated.
- 6 May 2026
- Published by IOP Publishing in Biomedical Physics & Engineering Express
- Vol. 12 (3) , 035022
A strategy of CT exam protocol to standardize groups of scanners using automated noise assessment and noise prediction for CT radiotherapy simulation
Objective. Standardizing clinical CT images enables consistent analysis of image data for target delineation, radiomics, and machine learning in personalized medicine. The process of managing the scanned protocols in various CT scanners for radiotherapy simulation is underexplored in the literature. This study uses noise evaluation and prediction models to harmonize CT protocols across scanner models and manufacturers, ensuring reliable data for radiotherapy planning. Approach. A global noise index (GNI) was calculated from 1581 clinical CT exams obtained on five scanners (three from vendor P and two from vendor S: S p and S c ). Exams were categorized by anatomical site. GNI was assessed (I) within the same model, (II) between models from the same manufacturer, and (III) across manufacturers. One-way ANOVA (I, III) and student t -tests (II) evaluated significance ( p < 0.05). Predictive models were created and validated with 90 further exams, establishing a reference GNI (GNI ref ) for future optimization. Results. GNI showed minor variations among P-type and between S p and S c scanners, but S scanners differed from P . Predictive model error ranged from 0.8 to 1.5 hounsfield units (HU). GNI differences between S and P scanners were S scanners had 1.5–2 HU higher GNI for the abdomen, pelvis, breast, and lungs. Conclusion. Scanners of the same model show slight variation; minor noise differences exist between manufacturers. Predictive modeling can estimate CT noise and support protocol optimization. The reference GNI of an anatomical site can be derived from sufficient CT exams, with or without the predictive mode; a 1–2 HU difference in GNI ref is achievable if the protocol is properly translated.
- 1 March 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 318 (3) , e250864
Optimizing Colorectal Liver Metastasis Ablation through Metabolic Imaging, Margin Assessment, and Biopsy (The OPTABLATE Prospective Trial)
Comprehensive multimodal assessment of the ablation zone led to immediate onsite reablation of 14% of colorectal liver metastases after initially insufficient ablation, and local tumor control improved after thermal ablation.
- 1 March 2026
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 318 (3) , e250864
Optimizing Colorectal Liver Metastasis Ablation through Metabolic Imaging, Margin Assessment, and Biopsy (The OPTABLATE Prospective Trial)
Comprehensive multimodal assessment of the ablation zone led to immediate onsite reablation of 14% of colorectal liver metastases after initially insufficient ablation, and local tumor control improved after thermal ablation.
- 24 April 2024
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 35 (7) , 1012-1021.e1
Histopathologic Changes after Yttrium-90 Radioembolization of Colorectal Liver Metastases: A Pilot Feasibility Study
- 24 April 2024
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 35 (7) , 1012-1021.e1
Histopathologic Changes after Yttrium-90 Radioembolization of Colorectal Liver Metastases: A Pilot Feasibility Study
- 10 January 2024
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 35 (4) , 523-532.e1
Three-Dimensional Margin as a Predictor of Local Tumor Progression after Microwave Ablation: Intraprocedural versus 4–8-Week Postablation Assessment
- 10 January 2024
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 35 (4) , 523-532.e1
Three-Dimensional Margin as a Predictor of Local Tumor Progression after Microwave Ablation: Intraprocedural versus 4–8-Week Postablation Assessment
- 13 November 2023
- Published by Wiley in Medical Physics
- Vol. 51 (3) , 2306-2310
Technical Note: Impact of impurities on Yttrium‐90 glass microsphere activity quantitation
Glass 90 Y microspheres are produced with known radionuclide impurities. These impurities are not independently monitored. Clinical instruments, including ionization chamber dose calibrators and positron emmission tomography (PET) cameras, can be much more sensitive in detecting signals from these impurities than to signals from 90 Y itself. The "typical" levels of 90 Y impurities have been studied to assess their impact on dosimetry during internal implantation, and for the management of waste. However, unaccounted-for decay spectra of impurities can also have an impact on dose calibrator and PET readings. Thus, even what might be considered negligibly small impurity fractions, can in principle cause substantial overestimates of the amount of 90 Y activity present in a sample. To our knowledge, quantitative effects of radionuclide impurities in glass microspheres on activity measurements have not been documented in the field. As activity quantitation for dosimetry and its correlations with outcome becomes more prevalent, the effects of impurities on measurements may remain unaccounted for in dosimetry studies. In this letter, we review theoretical and physical considerations that will result in asymmetric errors in quantitation from 90 Y impurities and estimate their typical and potential impact on clinical utilization. Among the common impurities 88 Y is of particular concern for its impact on 90 Y dose measurements because of its decay characteristics, along with other isotopes 91 Y and 46 Sc which can also impact measurements. The typical level of 88 Y impurities reported by the manufacturer should only cause small errors in dose calibrator and PET measurements made within the 12-day label-specified use-by period, up to 2.0% and 1.6%, respectively. However, the product specification max allowable impurity levels, specified by the manufacturer, leave open the potential for much greater bias from within the 12-day use-by period, potentially as high as 13.2% for dose calibrator measurements and 10.6% for PET from the 88 Y impurities. While typical levels of impurities appear to have acceptable impact on patient absorbed dose, it should be noted that they can have adverse effects on 90 Y radioactivity measurements. Furthermore, there is currently minimal independent verification and/or monitoring of impurity levels within the field.
- 13 November 2023
- Published by Wiley in Medical Physics
- Vol. 51 (3) , 2306-2310
Technical Note: Impact of impurities on Yttrium‐90 glass microsphere activity quantitation
Glass 90 Y microspheres are produced with known radionuclide impurities. These impurities are not independently monitored. Clinical instruments, including ionization chamber dose calibrators and positron emmission tomography (PET) cameras, can be much more sensitive in detecting signals from these impurities than to signals from 90 Y itself. The "typical" levels of 90 Y impurities have been studied to assess their impact on dosimetry during internal implantation, and for the management of waste. However, unaccounted-for decay spectra of impurities can also have an impact on dose calibrator and PET readings. Thus, even what might be considered negligibly small impurity fractions, can in principle cause substantial overestimates of the amount of 90 Y activity present in a sample. To our knowledge, quantitative effects of radionuclide impurities in glass microspheres on activity measurements have not been documented in the field. As activity quantitation for dosimetry and its correlations with outcome becomes more prevalent, the effects of impurities on measurements may remain unaccounted for in dosimetry studies. In this letter, we review theoretical and physical considerations that will result in asymmetric errors in quantitation from 90 Y impurities and estimate their typical and potential impact on clinical utilization. Among the common impurities 88 Y is of particular concern for its impact on 90 Y dose measurements because of its decay characteristics, along with other isotopes 91 Y and 46 Sc which can also impact measurements. The typical level of 88 Y impurities reported by the manufacturer should only cause small errors in dose calibrator and PET measurements made within the 12-day label-specified use-by period, up to 2.0% and 1.6%, respectively. However, the product specification max allowable impurity levels, specified by the manufacturer, leave open the potential for much greater bias from within the 12-day use-by period, potentially as high as 13.2% for dose calibrator measurements and 10.6% for PET from the 88 Y impurities. While typical levels of impurities appear to have acceptable impact on patient absorbed dose, it should be noted that they can have adverse effects on 90 Y radioactivity measurements. Furthermore, there is currently minimal independent verification and/or monitoring of impurity levels within the field.
- Open Access
Real-Time Split-Dose PET/CT-Guided Ablation Improves Colorectal Liver Metastasis Detection and Ablation Zone Margin Assessments without the Need for Repeated Contrast Injection
Background: Real-time split-dose PET can identify the targeted colorectal liver metastasis (CLM) and eliminate the need for repeated contrast administration before and during thermal ablation (TA). This study aimed to assess the added value of pre-ablation real-time split-dose PET when combined with non-contract CT in the detection of CLM for ablation and the evaluation of the ablation zone and margins. Methods: A total of 190 CLMs/125 participants from two IRB-approved prospective clinical trials using PET/CT-guided TA were analyzed. Based on detection on pre-TA imaging, CLMs were categorized as detectable, non-detectable, and of poor conspicuity on CT alone, and detectable, non-detectable, and low FDG-avidity on PET/CT after the initial dose. Ablation margins around the targeted CLM were evaluated using a 3D volumetric approach. Results: We found that 129/190 (67.9%) CLMs were detectable on CT alone, and 61/190 CLMs (32.1%) were undetectable or of poor conspicuity, not allowing accurate depiction and targeting by CT alone. Thus, the theoretical 5- and 10-mm margins could not be defined in these tumors (32.1%) using CT alone. When TA intraprocedural PET/CT images are obtained and inspected (fused PET/CT), only 4 CLM (2.1%) remained undetectable or had a low FDG avidity. Conclusions: The addition of PET to non-contrast CT improved CLM detection for ablation targeting, margin assessments, and continuous depiction of the FDG avid CLMs during the ablation without the need for multiple intravenous contrast injections pre- and intra-procedurally.
Open AccessReal-Time Split-Dose PET/CT-Guided Ablation Improves Colorectal Liver Metastasis Detection and Ablation Zone Margin Assessments without the Need for Repeated Contrast Injection
Background: Real-time split-dose PET can identify the targeted colorectal liver metastasis (CLM) and eliminate the need for repeated contrast administration before and during thermal ablation (TA). This study aimed to assess the added value of pre-ablation real-time split-dose PET when combined with non-contract CT in the detection of CLM for ablation and the evaluation of the ablation zone and margins. Methods: A total of 190 CLMs/125 participants from two IRB-approved prospective clinical trials using PET/CT-guided TA were analyzed. Based on detection on pre-TA imaging, CLMs were categorized as detectable, non-detectable, and of poor conspicuity on CT alone, and detectable, non-detectable, and low FDG-avidity on PET/CT after the initial dose. Ablation margins around the targeted CLM were evaluated using a 3D volumetric approach. Results: We found that 129/190 (67.9%) CLMs were detectable on CT alone, and 61/190 CLMs (32.1%) were undetectable or of poor conspicuity, not allowing accurate depiction and targeting by CT alone. Thus, the theoretical 5- and 10-mm margins could not be defined in these tumors (32.1%) using CT alone. When TA intraprocedural PET/CT images are obtained and inspected (fused PET/CT), only 4 CLM (2.1%) remained undetectable or had a low FDG avidity. Conclusions: The addition of PET to non-contrast CT improved CLM detection for ablation targeting, margin assessments, and continuous depiction of the FDG avid CLMs during the ablation without the need for multiple intravenous contrast injections pre- and intra-procedurally.
- Top Cited PapersOpen Access
- 14 May 2021
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 66 (10) , 10TR03
Advanced Monte Carlo simulations of emission tomography imaging systems with GATE
Built on top of the Geant4 toolkit, GATE is collaboratively developed for more than 15 years to design Monte Carlo simulations of nuclear-based imaging systems. It is, in particular, used by researchers and industrials to design, optimize, understand and create innovative emission tomography systems. In this paper, we reviewed the recent developments that have been proposed to simulate modern detectors and provide a comprehensive report on imaging systems that have been simulated and evaluated in GATE. Additionally, some methodological developments that are not specific for imaging but that can improve detector modeling and provide computation time gains, such as Variance Reduction Techniques and Artificial Intelligence integration, are described and discussed.
- 14 May 2021
- Published by IOP Publishing in Physics in Medicine & Biology
- Vol. 66 (10) , 10TR03
Top Cited PapersOpen AccessAdvanced Monte Carlo simulations of emission tomography imaging systems with GATE
Built on top of the Geant4 toolkit, GATE is collaboratively developed for more than 15 years to design Monte Carlo simulations of nuclear-based imaging systems. It is, in particular, used by researchers and industrials to design, optimize, understand and create innovative emission tomography systems. In this paper, we reviewed the recent developments that have been proposed to simulate modern detectors and provide a comprehensive report on imaging systems that have been simulated and evaluated in GATE. Additionally, some methodological developments that are not specific for imaging but that can improve detector modeling and provide computation time gains, such as Variance Reduction Techniques and Artificial Intelligence integration, are described and discussed.
- 1 March 2021
- Published by Edizioni Minerva Medica in The Quarterly Journal of Nuclear Medicine and Molecular Imaging
- Vol. 65 (1) , 1-3
Interventional molecular imaging
Interventional molecular imaging - The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 March;65(1):1-3 - Minerva Medica - Journals
- 1 March 2021
- Published by Edizioni Minerva Medica in The Quarterly Journal of Nuclear Medicine and Molecular Imaging
- Vol. 65 (1) , 1-3
Interventional molecular imaging
Interventional molecular imaging - The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 March;65(1):1-3 - Minerva Medica - Journals
- 1 March 2021
- Published by Edizioni Minerva Medica in The Quarterly Journal of Nuclear Medicine and Molecular Imaging
- Vol. 65 (1) , 20-31
Practice and prospects for PET/CT guided interventions
Practice and prospects for PET/CT guided interventions - The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 March;65(1):20-31 - Minerva Medica - Journals
- 1 March 2021
- Published by Edizioni Minerva Medica in The Quarterly Journal of Nuclear Medicine and Molecular Imaging
- Vol. 65 (1) , 20-31
Practice and prospects for PET/CT guided interventions
Practice and prospects for PET/CT guided interventions - The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2021 March;65(1):20-31 - Minerva Medica - Journals